While our research did not provide evidence that SPSL activation of UCP1, the reported co-activation of AMPK and UCP1 through the PGC1α pathway suggests further investigation into the role of UCP1 in the anti-obesity effects of SPSL [55]. This evidence concerns the gene PPARGC1A and obesity due to melanocortin 4 receptor deficiency.